An elite team of young, transpa­cif­ic sci­en­tists out of Har­vard and MIT starts plow­ing next-gen cell ther­a­py tech field

This isn’t the com­plete sto­ry about the lat­est biotech up­start to raise its head in the cell ther­a­py field. It’s not even half the sto­ry …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.